Announced selection of rinzimetostat RP3D in combination with darolutamide for Himalayas-1 Phase 3 global registrational trial in post-abiraterone mCRPC, expected to initiate in 1H 2026 Reported ...

A new study from the University of St Andrews suggests weight-loss drugs like Ozempic taken around pregnancy do not raise the ...

Russian scientists have found a method that opens the way to the creation of fundamentally new drugs for the treatment of ...

GLP-1 receptor agonists may not raise the risk for diabetic ketoacidosis or pancreatitis among adults with type 1 diabetes, ...

Nearly every woman with breast cancer has at least one menopausal symptom. Yet many patients feel their quality-of-life needs ...

Bolsover District Council has identified 61 sites as ‘available’ in the region for potential housing developments in and ...

Companies are adopting diverse approaches to reducing unwanted toxicities associated with cell and gene therapy.

GLP-1RAs significantly reduce major cardiovascular events, mortality, and other clinically significant complications in ...

Axsome Therapeutics' Auvelity has become the first non-antipsychotic therapy for agitation in patients with Alzheimer's ...

The biology behind muscle pain: calcium chaos, microscopic damage, and the overlooked mechanism that explains how statins can ...

Research shows that awareness of GLP-1 medications is on the rise as Americans explore these agonists for a variety of ...